2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T546d,

Summary Table

Category	Details
Risk Factors	Prematurity (strongest association), low birth weight, maternal first-trimester rubella infection, high-altitude birth, female sex (2:1 female-to-male ratio)
Etiology	Failure of the ductus arteriosus to close after birth due to persistent prostaglandin E2 effect and/or inadequate oxygen-mediated constriction of ductal smooth muscle
Patient Presentation	Asymptomatic murmur in a neonate or infant; in hemodynamically significant PDA: poor feeding, failure to thrive, tachypnea, recurrent lower respiratory tract infections, difficulty weaning from mechanical ventilation in premature infants
Classic Physical Exam	Continuous "machinery" murmur best heard at the left upper sternal border (infraclavicular area), bounding (water-hammer) pulses, widened pulse pressure, hyperactive precordium, differential cyanosis in the setting of Eisenmenger physiology (lower extremities cyanotic, upper extremities pink)
Key Diagnostic Results	Echocardiography with Doppler showing left-to-right shunt across the ductus; chest X-ray may show cardiomegaly and increased pulmonary vascular markings
Management	Premature infants: indomethacin or ibuprofen (prostaglandin synthesis inhibitors) for pharmacologic closure. Term infants and older children: transcatheter device closure or surgical ligation. Prostaglandin E1 (alprostadil) is used to keep the ductus open in ductal-dependent congenital heart lesions
Keywords	"Machinery murmur," "continuous murmur at left upper sternal border," "bounding pulses," "widened pulse pressure," "premature infant with murmur," "maternal rubella"

1. Pathophysiology

The ductus arteriosus is a normal fetal vascular structure connecting the pulmonary artery to the descending aorta. During fetal life, this channel diverts blood away from the high-resistance, fluid-filled lungs and directs it toward the placenta for gas exchange. Two factors keep the ductus open in utero: low oxygen tension in fetal blood and circulating prostaglandin E2 (produced primarily by the placenta).

At birth, two events trigger ductal closure. First, the infant's first breaths cause a rise in arterial oxygen tension ($PaO_2$), which directly constricts the smooth muscle of the ductal wall. Second, removal of the placenta eliminates the primary source of prostaglandin E2, lowering its circulating levels. The combination of increased oxygen and decreased prostaglandin leads to functional closure within 24 to 72 hours, followed by anatomical closure (fibrosis into the ligamentum arteriosum) over the next 2 to 3 weeks.

In PDA, this closure fails. Because aortic pressure exceeds pulmonary artery pressure after birth, blood shunts left-to-right (aorta to pulmonary artery) through the open ductus. This creates a volume overload on the pulmonary vasculature and the left heart (left atrium and left ventricle), since the excess blood returns via the pulmonary veins. Over time, the left atrium and left ventricle dilate. The continuous pressure gradient between the aorta and pulmonary artery (present in both systole and diastole) is what produces the characteristic continuous machinery murmur. The murmur is continuous because, unlike most left-to-right shunts, the aortic pressure remains higher than pulmonary artery pressure throughout the entire cardiac cycle.

The widened pulse pressure and bounding pulses occur because blood "runs off" from the aorta into the lower-resistance pulmonary circulation during diastole, causing the diastolic pressure to drop while systolic pressure is maintained or even elevated due to the increased stroke volume from left ventricular volume overload.

Premature infants are especially vulnerable because their ductal tissue is more sensitive to prostaglandins and less responsive to oxygen-mediated constriction. This is why pharmacologic intervention with prostaglandin synthesis inhibitors (NSAIDs) is effective in this population.

If left uncorrected, a large PDA can eventually cause pulmonary vascular remodeling and Eisenmenger syndrome, where pulmonary pressures exceed systemic pressures and the shunt reverses to right-to-left. At this point, differential cyanosis appears: the lower extremities (supplied by the descending aorta, which receives deoxygenated blood from the pulmonary artery via the reversed ductus) become cyanotic, while the upper extremities and head (supplied by the aortic arch proximal to the ductus) remain pink.

2. Classification and Clinical Manifestation

Classification	Shunt Direction	Clinical Manifestation
Small PDA	Left-to-right (minimal)	Usually asymptomatic; soft continuous murmur or no audible murmur; normal growth and development; detected incidentally on echocardiography
Moderate PDA	Left-to-right (moderate volume)	Continuous machinery murmur at the left infraclavicular region, mildly widened pulse pressure, mild tachypnea with feeds, borderline weight gain
Large / Hemodynamically Significant PDA	Left-to-right (large volume)	Loud continuous murmur with thrill, bounding pulses, wide pulse pressure, tachypnea, tachycardia, hepatomegaly, failure to thrive, recurrent respiratory infections, signs of congestive heart failure
Eisenmenger PDA (irreversible)	Right-to-left (reversed)	Differential cyanosis (cyanotic lower extremities with pink upper extremities), clubbing of toes but not fingers, loss of the continuous murmur (replaced by a loud P2 component), signs of right heart failure; surgical or device closure is contraindicated at this stage

In premature neonates, the presentation is often a failure to wean from ventilatory support, worsening respiratory status, apneic episodes, and hemodynamic instability with bounding pulses and a hyperdynamic precordium rather than the classic murmur heard in older infants.

3. Diagnostic Workup

Test	Role	Key Findings
Transthoracic echocardiography with color Doppler	Best initial test AND confirmatory test (gold standard)	Direct visualization of the ductus, direction and velocity of shunt flow, assessment of left atrial and left ventricular dilation, estimation of pulmonary artery pressure
Chest X-ray	Supportive/screening	Cardiomegaly (LA and LV enlargement), increased pulmonary vascular markings, prominent pulmonary artery segment; in premature infants may show pulmonary edema
Electrocardiogram (ECG)	Supportive	Left atrial enlargement, left ventricular hypertrophy in moderate-to-large PDA; right ventricular hypertrophy if pulmonary hypertension has developed
Cardiac catheterization	Reserved for borderline or complex cases	Measures pulmonary vascular resistance and reactivity, confirms shunt fraction ($Q_p/Q_s$ ratio), used when Eisenmenger physiology is suspected and reversibility needs assessment; also serves as an intervention platform for transcatheter closure

Echocardiography is the cornerstone of PDA diagnosis. It is noninvasive, widely available, and provides all the information needed: ductus size, shunt direction, volume of left heart overload, and estimated pulmonary artery pressures. In nearly all clinical and exam scenarios, echocardiography is both the best initial and the most accurate test.

Chest X-ray is often the first study obtained when an infant presents with respiratory symptoms or a murmur. In PDA, the X-ray shows signs of left heart volume overload: cardiomegaly with prominent pulmonary vasculature. However, the X-ray is nondiagnostic for PDA and serves only to raise suspicion.

Cardiac catheterization is not routinely needed. Its role is limited to cases where the degree of pulmonary hypertension is uncertain and you need to determine whether the pulmonary vascular changes are still reversible before considering closure. A step-up in oxygen saturation at the level of the pulmonary artery (compared to the right ventricle) confirms a left-to-right shunt at the ductal level.

From a test-writer perspective, if you are given a premature neonate with a continuous murmur, bounding pulses, and widened pulse pressure, the next best step is echocardiography. Do not be distracted by answer choices suggesting catheterization or CT angiography.

4. Management and Treatment

Clinical Scenario	Management	Details
Premature infant with hemodynamically significant PDA	Pharmacologic closure: paracetamol (first-line), ibuprofen, or indomethacin	Paracetamol (acetaminophen): 15 mg/kg PO or IV every 6 hours for 3 to 7 days. Now preferred first-line due to comparable closure rates with a significantly better side effect profile (no renal impairment, no platelet dysfunction, no GI complications). Ibuprofen: 10 mg/kg IV initial dose, then 5 mg/kg at 24 and 48 hours. Fewer renal side effects than indomethacin and preferred when a COX inhibitor is chosen. Indomethacin: 0.1 to 0.25 mg/kg IV, given as 3 doses at 12- to 24-hour intervals. Most nephrotoxic of the three but has the longest track record. All three act by inhibiting prostaglandin synthesis, but paracetamol does so via the peroxidase segment of COX rather than direct COX-1/COX-2 inhibition
Premature infant failing pharmacologic therapy	Surgical ligation or transcatheter closure	Indicated when pharmacologic therapy fails after 1 to 2 courses, or when all pharmacologic agents are contraindicated
Term infant or child with PDA	Transcatheter device closure (preferred) or surgical ligation	Pharmacologic closure with any agent is not effective in term infants because their ductal tissue is structurally different and less prostaglandin-dependent. Closure is recommended even for small PDAs in most guidelines to eliminate endocarditis risk
Ductal-dependent congenital heart lesion (e.g., transposition of great arteries, critical coarctation, hypoplastic left heart)	Prostaglandin E1 (alprostadil) infusion to maintain ductal patency	Dose: 0.05 to 0.1 mcg/kg/min IV continuous infusion. Side effects include apnea (prepare to intubate), fever, flushing, hypotension
Eisenmenger syndrome (irreversible pulmonary hypertension)	Closure is contraindicated	Closing the ductus removes the pressure relief pathway for the right ventricle, leading to acute right heart failure and death. Management is medical: pulmonary vasodilators, supplemental oxygen, and eventual consideration for heart-lung transplant

Contraindications to indomethacin and ibuprofen (but not to paracetamol): necrotizing enterocolitis (NEC) or suspected NEC, active renal insufficiency (serum creatinine above 1.6 to 1.8 mg/dL), platelet count below 50,000/mcL, active bleeding including intracranial hemorrhage, and ductal-dependent cardiac lesions. This is a key advantage of paracetamol: in scenarios where COX inhibitors are contraindicated due to renal failure, thrombocytopenia, or NEC, paracetamol remains a viable pharmacologic option before resorting to surgical intervention. The only shared contraindication across all three agents is ductal-dependent cardiac lesions, and the only contraindication relatively unique to paracetamol is severe hepatic dysfunction.

Critical exam concept: indomethacin/ibuprofen/paracetamol close the PDA, while prostaglandin E1 keeps it open. These drugs work in opposite directions, and test-writers frequently present scenarios requiring you to decide which one to use. If a newborn has cyanotic heart disease depending on ductal flow for survival, the answer is prostaglandin E1. If a premature infant has a symptomatic PDA causing heart failure or ventilator dependence, the answer is paracetamol (or ibuprofen/indomethacin). If the question stem includes renal insufficiency or thrombocytopenia alongside a symptomatic PDA, they are steering you toward paracetamol as the answer.

Endocarditis prophylaxis is recommended for the first 6 months after transcatheter device closure or surgical ligation, or indefinitely if there is a residual shunt adjacent to prosthetic material.

5. Differential Diagnosis and Distractors

Diagnosis	Why It Is Similar	Key Discriminator
Ventricular Septal Defect (VSD)	Both cause left-to-right shunts, volume overload of the left heart, and present with murmur and signs of heart failure in infants	VSD produces a holosystolic (pansystolic) murmur at the left lower sternal border, not a continuous murmur. The murmur does not extend into diastole. Pulses and pulse pressure are typically normal
Aortopulmonary window	Extremely similar hemodynamics to PDA (aorta-to-pulmonary artery communication, left-to-right shunt, continuous murmur possible)	Aortopulmonary window is a direct communication between the ascending aorta and pulmonary trunk (not via a ductus). Echocardiography differentiates the two anatomically. This is rare and is a surgical (not pharmacologic) diagnosis
Coronary arteriovenous fistula	Can produce a continuous murmur due to flow from a high-pressure to a low-pressure system	Murmur location varies depending on fistula site (often not at the left infraclavicular area). Echocardiography and angiography reveal the fistula
Venous hum (benign)	Produces a continuous murmur in pediatric patients	Venous hum is heard in the neck/supraclavicular area, changes with head turning or compression of the ipsilateral jugular vein, and disappears in the supine position. There are no hemodynamic consequences
Truncus arteriosus	Can present with a murmur and increased pulmonary blood flow in a cyanotic neonate	Truncus arteriosus causes cyanosis from the outset (single outflow tract with mixing). PDA with left-to-right shunt does not cause cyanosis unless Eisenmenger develops
Aortic regurgitation	Can cause bounding pulses and widened pulse pressure	The murmur of aortic regurgitation is a diastolic decrescendo murmur at the left sternal border, not a continuous machinery murmur

6. Traps and High-Yield Pearls

The single most tested trap in PDA questions is confusing when to close the ductus versus when to keep it open. A premature baby with a continuous murmur, bounding pulses, and respiratory distress needs the ductus closed (indomethacin or ibuprofen). A cyanotic newborn with a ductal-dependent lesion (e.g., transposition of great arteries, critical pulmonary stenosis, hypoplastic left heart syndrome) needs the ductus kept open with prostaglandin E1. Test-writers will present both scenarios and expect you to choose the correct drug. Selecting indomethacin for a ductal-dependent lesion or prostaglandin E1 for a symptomatic PDA is a frequently exploited error.

Another common trap involves the murmur description. Students who memorize "continuous murmur equals PDA" may overlook that a venous hum is also continuous. The distinguishing features are that a venous hum changes with position and head rotation, while the PDA machinery murmur does not. If the vignette describes a healthy child with a continuous murmur that disappears when lying down, the answer is a benign venous hum, not PDA.

Watch for questions about Eisenmenger physiology in the setting of PDA. Once the shunt reverses, closure is contraindicated. A question may describe a patient with PDA and long-standing pulmonary hypertension who now has differential cyanosis (blue toes, pink fingers). This is the signal for irreversible Eisenmenger syndrome, and the correct answer is medical management only, not surgery or device closure.

Finally, remember that NSAIDs work only in premature infants. If a term infant or older child is described with a PDA, the correct treatment is transcatheter device closure or surgical ligation. Choosing indomethacin for a 2-year-old with PDA is incorrect and is a favorite wrong answer on exams.

1e:["$","$L2d",null,{"article":{"id":"4bf8434a-4216-4e31-b69c-a544497620e5","title":"Patent Ductus Arteriosus (PDA)","content":"$2e","category":"KV-Limfatik","created_at":"2026-05-22T13:03:05.370272+00:00","status":"published","subcategory":null},"questionCount":3,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]